Redsense Cares about Your Safety
Our vision is to save lives by detecting blood loss, using a patented core technology that utilizes fiber optics.
The Redsense blood loss detection solution is specifically designed to detect blood leakage through core technology utilizing fiber optics. Detected blood triggers a visual and audible alarm; thus giving patients, nurses and caregivers some extra peace of mind.
Redsense Medical completes a directed new share issue of 1,500,000 shares, raising approximately SEK 73 million and the company’s largest shareholder has sold shares
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Press Release Halmstad 8 […]
FINANCIAL SUMMARY Second quarter, 1 April – 30 June 2020 The Redsense Medical Group • Net sales amounted to kSEK 5,292 (2,758), a 92 percent increase compared with the corresponding period in 2019. • Profit or loss before tax amounted to kSEK 93 (-1,388). The Swedish Parent Company • Net sales amounted to kSEK 3,946 (2,060). […]
Redsense Medical AB announces today that an evaluation programme is launching in the Netherlands to test a new version of the Redsense Alarm, with additional functionality that has been developed in response to clinical experiences – a direct connection for the unit into the nurse call system of the clinic. The evaluation will comprise 100-150 […]
As of today, the Annual Report for Redsense Medical AB (publ.) For the 2019 financial year is available for download. Rapport på Svenska Report in English A printed version can be ordered from: Redsense Medical AB Gyllenhammars väg 26 302 92 Halmstad